WPSG
LXRX icon

Wealth & Pension Services Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Wealth & Pension Services Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$32K Hold
10,750
– – 0.02% 119
2019
Q2 		$68K Hold
10,750
– – 0.05% 119
2019
Q1 		$60K Buy
+10,750
New +$65.3K 0.05% 113

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealth & Pension Services Group's LXRX Position: Q3 2019 in Review

Wealth & Pension Services Group held its Lexicon Pharmaceuticals (LXRX) position steady in Q3 2019 at 10,750 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #119.

Wealth & Pension Services Group first reported a position in LXRX in Q1 2019 and has held it in 3 quarters since. The position peaked at $68K in Q2 2019. 103 funds tracked by Wall St. Rank hold LXRX as of Q3 2019.

  • Wealth & Pension Services Group held 10,750 shares of Lexicon Pharmaceuticals worth $32K as of Q3 2019.
  • Wealth & Pension Services Group left its Lexicon Pharmaceuticals share count unchanged in Q3 2019.
  • Lexicon Pharmaceuticals made up 0.02% of Wealth & Pension Services Group's portfolio in Q3 2019, its #119 holding.
  • Wealth & Pension Services Group first reported a position in Lexicon Pharmaceuticals in Q1 2019 and has held it in 3 quarters since.
  • Wealth & Pension Services Group's Lexicon Pharmaceuticals position peaked at $68K in Q2 2019.
  • 103 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2019.

Based on Wealth & Pension Services Group's 13F filing for Q3 2019, filed 19 Nov 2019.